Stryker Corp SYK

Revenue Intelligence Report • 73 quarters of SEC filing data • Updated 2026-10-14 • Data through 2026-06-30

Stryker Corp's latest quarterly revenue is $6.6B for the period ending 2026-06-30. The model projects $27.7B across the next four quarters (+7.2% versus the preceding four quarters). The forecast uses SG&A data; model selection and estimation exclude the latest quarter, whose retrospective holdout error is 0.2%. These are statistical associations, not estimates of the causal effect of spending.

Investment Thesis

The ARDL forecast is based on reported revenue and SG&A data through 2026-06-30. Training MAPE measures fit to historical data; the separately reported holdout error measures a withheld quarter. Spending coefficients describe associations and do not establish causation.

Next 4 Quarters
$27.7B
+7.2% YoY
R&D Elasticity
0.49x
SG&A Elasticity
0.81x
Training Fit
3.7% MAPE
Retrospective holdout (Q2 FY2026): The model predicted $6.60B vs the actual $6.59B — an error of 0.2%.
Retrospective one-quarter holdout: model fitting and selection exclude this quarter. Historical inputs use the latest available restatements, so this is not a preserved real-time forecast.

Revenue Forecast

SYK Revenue Forecast

Quarterly Detail

QuarterModel ForecastActual95% RangeYoY GrowthStatus
Q2 FY2026
Period end 2026-06-30		 $6.60B $6.59B $5.90B–$7.39B +9.6% ✓ In range
Q3 FY2026
Period end 2026-09-30		 $6.60B $5.63B–$7.75B +9.0%
Q4 FY2026
Period end 2026-12-31		 $7.30B $6.00B–$8.89B +1.9%
Q1 FY2027
Period end 2027-03-31		 $6.61B $5.27B–$8.29B +9.8%
Q2 FY2027
Period end 2027-06-30		 $7.19B $5.58B–$9.26B +9.1%

Seasonal Factors

Multiplicative seasonal adjustment: These factors capture Stryker Corp's systematic quarterly revenue patterns relative to the trend model. A factor of 1.05 means that quarter typically runs 5% above the underlying trend; 0.95 means 5% below. Factors are computed as the median of (actual / fitted) across all available quarters.
Fiscal QuarterSeasonal Factorvs TrendInterpretationObs.
FQ1 (Jan–Mar) 0.9889 -1.1% In line with trend 17
FQ2 (Apr–Jun) 0.9914 -0.9% In line with trend 17
FQ3 (Jul–Sep) 0.9945 -0.5% In line with trend 17
FQ4 (Oct–Dec) 1.036 +3.6% +3.6% above trend 17

Spending and Revenue

SYK Spending Timing
Reading this chart: Each line shows the cumulative revenue association with a 1% change in spending over subsequent quarters. These estimates describe historical associations and do not establish causation.

Time-Varying Spending Associations

Time-varying analysis: A penalized spline model (GAM) tracks the association between log spending and log revenue over 73 quarters. Its coefficients describe conditional historical associations, not causal returns on spending.
Current SG&A elasticity: 0.8757x • R&D elasticity: -0.1563x
The model-term chart shows relative absolute term magnitudes. Its percentages are not shares of revenue or causal contributions to growth.

Want this analysis for your portfolio?

I build custom revenue intelligence reports for investors and companies using SEC filing data, econometric modeling, and AI-powered insights.

Get in Touch

Data sourced from SEC EDGAR XBRL filings. SEC source data. Forecast model: ARDL; spending associations: ARDL (log-log) with 73 quarters. This analysis is for informational purposes only and does not constitute investment advice.

More in Healthcare

BSX WAT CRL GILD PFE ALGN BMY HOLX